Results 71 to 80 of about 1,001,271 (265)

Current status of mini-gastric bypass

open access: yesJournal of Minimal Access Surgery, 2016
Mini-gastric bypass (MGP) is a promising bariatric procedure. Tens of thousands of this procedure have been performed throughout the world since Rutledge performed the first procedure in the United States of America in 1997.
Kamal K Mahawar   +6 more
doaj   +1 more source

Chylous ascites as a late complication of one anastomosis gastric bypass-minigastric bypass: case report

open access: yesBMC Surgery, 2020
Background One anastomosis gastric bypass- minigastric bypass (OAGB-MGB) is an emerging bariatric surgery that is being endorsed by surgeons worldwide. Internal herniation is a rare and dreaded complication after malabsorptive bariatric procedures, which
Ibrahim Abu Shakra   +9 more
doaj   +1 more source

Long‐term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux‐en‐Y gastric bypass (RYGB) participants in the Longitudinal Assessment of Bariatric Surgery (LABS) study

open access: yesSurgery, 2018
Background: Data from a US multicenter longitudinal study of bariatric surgery were used to compare weight change (primary outcome) and comorbidities (secondary outcome) in patients who underwent sleeve gastrectomy versus Roux‐en‐Y gastric bypass ...
Bestoun Ahmed   +7 more
semanticscholar   +1 more source

Differential Changes in Dietary Habits after Gastric Bypass Versus Gastric Banding Operations [PDF]

open access: yes, 2018
Background: Reduction of food intake is an important mechanism by which bariatric procedures reduce body weight. However, only few studies have systematically assessed what patients actually eat after different types of bariatric operations.
Ernst, Barbara   +3 more
core  

Development of type 2 diabetes mellitus thirty-one years after Billroth II in a patient asking for diabetes surgery [PDF]

open access: yes, 2016
Introduction: Diabetes surgery in obese and slim patients seems to be a superior alternative to the current medical treatment. Gastric bypass is an alternative treat- ment for diabetes.
A. Reyes-Ortiz   +9 more
core  

Gastrojejunostomy junction perforation resulting from Dobhoff tube insertion in a patient with a history of Roux-en-Y surgery: a case report

open access: yesJournal of Medical Case Reports
Background Gastrojejunostomy junction perforation is a rare yet critical complication associated with enteral tube placement, presenting unique challenges in patients with a history of Roux-en-Y gastric bypass surgery.
Monty Khela   +5 more
doaj   +1 more source

Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans

open access: yesObesity Science & Practice, 2017
Summary Objective Unlike gastric banding or sleeve gastrectomy procedures, intestinal bypass procedures, Roux‐en‐Y gastric bypass in particular, lead to rapid improvements in glycaemia early after surgery.
A. D. Miras   +11 more
doaj   +1 more source

The life expectancy of patients with metabolic syndrome after weight loss: study protocol for a randomized clinical trial (LIFEXPE-RT)

open access: yesTrials, 2019
Background To date, surgeons and physicians have found positive results treating metabolic syndrome with surgical and non-surgical weight loss therapies.
Oral Ospanov   +3 more
doaj   +1 more source

Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass [PDF]

open access: yes, 2018
Aims/hypothesis: Glucagon-like peptide-1 (GLP-1) receptors are highly overexpressed in benign insulinomas, permitting in vivo tumour visualisation with GLP-1 receptor scanning.
Callery, M.   +7 more
core  

Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass

open access: yesBiomolecules
Bariatric surgery involves major changes in the anatomy and physiology of the gastrointestinal tract, which may alter oral drug bioavailability and efficacy. Phosphodiesterase-5 inhibitor (PDE5i) drugs are the first-line treatment of erectile dysfunction,
Daniel Porat   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy